B of A Securities Maintains Buy on Sana Biotechnology, Lowers Price Target to $6

Benzinga · 3d ago
B of A Securities analyst Alex Stranahan maintains Sana Biotechnology (NASDAQ:SANA) with a Buy and lowers the price target from $7 to $6.